On the fly News and insights, exclusive to thefly.com

CCXI

ChemoCentryx

$37.00 /

+18 (+3.00%)

, FSLR

First Solar

$32.00 /

+15 (+2.00%)

09:51
10/29/20
10/29
09:51
10/29/20
09:51

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. ChemoCentryx (CCXI) downgraded to Neutral from Overweight at JPMorgan with analyst Anupam Rama saying he views the Phase 2 AURORA results for avacopan in hidradenitis suppurativa as "mixed." 2. First Solar (FSLR) downgraded to Neutral from Overweight at JPMorgan with analyst Paul Coster saying after rallying 67% year-to-date, the stock is now trading close to the price target and at "historically-elevated" multiples. 3. Exact Sciences (EXAS) downgraded to Neutral from Buy at UBS with analyst Dan Brennan saying the company's acquisition of Thrive is "strategically sound," but at current levels, the risk/reward on the stock is "more balanced." 4. C.H. Robinson (CHRW) downgraded to Equal Weight from Overweight at Stephens with analyst Jack Atkins saying he continues to view C.H. Robinson as a long-term winner as the third-party logistics industry consolidates, he prefers to move to the sidelines until there is greater visibility into the volume growth that he sees as necessary to drive revenue and profitability growth. 5. CAE (CAE) downgraded to Hold from Buy at Canaccord with analyst Doug Taylor citing valuation and a lack of visibility on growth reacceleration. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

CCXI

ChemoCentryx

$37.00 /

+18 (+3.00%)

FSLR

First Solar

$32.00 /

+15 (+2.00%)

EXAS

Exact Sciences

$33.00 /

+17 (+10.00%)

CHRW

C.H. Robinson

$31.00 /

+17 (+5.00%)

CAE

CAE

$33.00 /

+12 (+10.00%)

  • 10

    Nov

  • 17

    Nov

  • 07

    Jul

  • 11

    Jun

  • 11

    Jun

  • 17

    Sep

  • 17

    Sep

CCXI ChemoCentryx
$37.00 /

+18 (+3.00%)

10/29/20 SVB Leerink
ChemoCentryx price target raised to $84 from $75 at SVB Leerink
10/29/20 SVB Leerink
ChemoCentryx price target raised to $84 from $75 at SVB Leerink
10/29/20 Wells Fargo
ChemoCentryx price target lowered to $70 from $79 at Wells Fargo
10/29/20 Wells Fargo
ChemoCentryx price target lowered to $70 from $79 at Wells Fargo
10/29/20 JPMorgan
JPMorgan downgrades ChemoCentryx to Neutral after 'mixed' data
10/29/20 JPMorgan
JPMorgan downgrades ChemoCentryx to Neutral after 'mixed' data
10/29/20 JPMorgan
ChemoCentryx downgraded to Neutral from Overweight at JPMorgan
10/29/20 JPMorgan
ChemoCentryx downgraded to Neutral from Overweight at JPMorgan
FSLR First Solar
$32.00 /

+15 (+2.00%)

10/29/20 JPMorgan
First Solar downgraded to Neutral after 67% rally at JPMorgan
10/29/20 JPMorgan
First Solar downgraded to Neutral after 67% rally at JPMorgan
10/29/20 JPMorgan
First Solar downgraded to Neutral from Overweight at JPMorgan
10/29/20 JPMorgan
First Solar downgraded to Neutral from Overweight at JPMorgan
10/28/20 Raymond James
First Solar price target raised to $90 from $80 at Raymond James
10/28/20 Raymond James
First Solar price target raised to $90 from $80 at Raymond James
10/28/20 Roth Capital
First Solar price target raised to $110 from $100 at Roth Capital
10/28/20 Roth Capital
First Solar price target raised to $110 from $100 at Roth Capital
EXAS Exact Sciences
$33.00 /

+17 (+10.00%)

10/29/20 UBS
Exact Sciences downgraded to Neutral from Buy at UBS
10/29/20 UBS
Exact Sciences downgraded to Neutral from Buy at UBS
10/28/20
Fly Intel: Top five analyst downgrades
10/28/20
Fly Intel: Top five analyst downgrades
10/28/20 Benchmark
Exact Sciences price target raised to $145 from $110 at Benchmark
10/28/20 Benchmark
Exact Sciences price target raised to $145 from $110 at Benchmark
10/28/20 SVB Leerink
Exact Sciences price target raised to $160 from $115 at SVB Leerink
10/28/20 SVB Leerink
Exact Sciences price target raised to $160 from $115 at SVB Leerink
CHRW C.H. Robinson
$31.00 /

+17 (+5.00%)

10/29/20 Wells Fargo
C.H. Robinson price target lowered to $78 from $92 at Wells Fargo
10/29/20 Wells Fargo
C.H. Robinson price target lowered to $78 from $92 at Wells Fargo
10/29/20 Stephens
C.H. Robinson downgraded to Equal Weight at Stephens
10/29/20 Stephens
C.H. Robinson downgraded to Equal Weight at Stephens
10/29/20 Stephens
C.H. Robinson downgraded to Equal Weight from Overweight at Stephens
10/29/20 Stephens
C.H. Robinson downgraded to Equal Weight from Overweight at Stephens
10/28/20 Morgan Stanley
C.H. Robinson's next few quarters to be 'very challenging,' says Morgan Stanley
10/28/20 Morgan Stanley
C.H. Robinson's next few quarters to be 'very challenging,' says Morgan Stanley
CAE CAE
$33.00 /

+12 (+10.00%)

10/29/20 Canaccord
CAE downgraded to Hold from Buy at Canaccord
10/29/20 Canaccord
CAE downgraded to Hold from Buy at Canaccord
09/30/20 BMO Capital
CAE upgraded to Outperform from Market Perform at BMO Capital
09/30/20 BMO Capital
CAE upgraded to Outperform from Market Perform at BMO Capital
08/14/20 TD Securities
CAE price target raised to C$21 from C$20 at TD Securities
08/14/20 TD Securities
CAE price target raised to C$21 from C$20 at TD Securities
08/13/20 RBC Capital
CAE price target lowered to C$27 from C$28 at RBC Capital
08/13/20 RBC Capital
CAE price target lowered to C$27 from C$28 at RBC Capital

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.